![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 1976 | Founding Date 1929 | Founding Date 1928 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 18,077 | Employees 5,358 | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 34.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income N/A | Net income €445.1m (FY, 2025) | Net income €1.6b (FY, 2025) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company